Frisoni GB, Molinuevo JL, Altomare D, Carrera E, Barkhof F, Berkhof J, et al. Precision prevention of Alzheimer’s and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies. Alzheimers Dement. 2020;16(10):1457–68. https://doi.org/10.1002/alz.12132.
Article
PubMed
Google Scholar
Altomare D, Molinuevo JL, Ritchie C, Ribaldi F, Carrera E, Dubois B, Jessen F, McWhirter L, Scheltens P, van der Flier WM, Vellas B, Démonet JF, Frisoni GB. Brain Health Services: Organization, structure and challenges for implementation. A user manual for Brain Health Services – Part 1 of 6. Alzheimers Res Ther. 2021. https://doi.org/10.1186/s13195-021-00827-2.
Visser LNC, Minguillon C, Sánchez-Benavides G, Abramowicz M, Altomare D, Fauria K, Frisoni GB, Georges J, Ribaldi F, Scheltens P, van der Schaar J, Zwan M, van der Flier WM, Molinuevo JL. Dementia risk communication. A user manual for Brain Health Services – Part 3 of 6. Alzheimers Res Ther. 2021. https://doi.org/10.1186/s13195-021-00840-5.
Solomon A, Stephen R, Altomare D, Carrera E, Frisoni GB, Kulmala J, Molinuevo JL, Nilsson P, Ngandu T, Ribaldi F, Vellas B, Scheltens P, Kivipelto M. Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services – Part 4 of 6. Alzheimers Res Ther. 2021. https://doi.org/10.1186/s13195-021-00875-8.
Brioschi Guevara A, Bieler M, Altomare D, Berthier M, Csajka C, Dautricourt S, Démonet JF, Dodich A, Frisoni GB, Miniussi C, Molinuevo JL, Ribaldi F, Scheltens P, Chételat G. Protocols for cognitive enhancement. A user manual for Brain Health Services – Part 5 of 6. Alzheimers Res Ther. 2021. https://doi.org/10.1186/s13195-021-00844-1.
Milne R, Altomare D, Ribaldi F, Molinuevo JL, Frisoni GB, Brayne C. Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services – Part 6 of 6. Alzheimers Res Ther. 2021. https://doi.org/10.1186/s13195-021-00885-6.
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673–734. https://doi.org/10.1016/S0140-6736(17)31363-6.
Article
PubMed
Google Scholar
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–46. https://doi.org/10.1016/S0140-6736(20)30367-6.
Article
PubMed
PubMed Central
Google Scholar
Arenaza-Urquijo EM, Wirth M, Chételat G. Cognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease. Front Aging Neurosci. 2015;7:134. https://doi.org/10.3389/fnagi.2015.00134.
Article
CAS
PubMed
PubMed Central
Google Scholar
Peelle JE, Troiani V, Grossman M, Wingfield A. Hearing loss in older adults affects neural systems supporting speech comprehension. J Neurosci. 2011;31(35):12638–43. https://doi.org/10.1523/JNEUROSCI.2559-11.2011.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hughes TF, Ganguli M. Modifiable midlife risk factors for late-life cognitive impairment and dementia. Curr Psychiatry Rev. 2009;5(2):73–92. https://doi.org/10.2174/157340009788167347.
Article
PubMed
PubMed Central
Google Scholar
Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6:1246–58.
Article
PubMed
PubMed Central
Google Scholar
Kivimäki M, Singh-Manoux A, Pentti J, Sabia S, Nyberg ST, Alfredsson L, et al. Physical inactivity, cardiometabolic disease, and risk of dementia: an individual-participant meta-analysis. BMJ. 2019;365:l1495. https://doi.org/10.1136/bmj.l1495.
Article
PubMed
PubMed Central
Google Scholar
Shalev D, Arbuckle MR. Metabolism and memory: obesity, diabetes, and dementia. Biol Psychiatry. 2017;82(11):e81–3. https://doi.org/10.1016/j.biopsych.2017.09.025.
Article
PubMed
PubMed Central
Google Scholar
Peters R, Ee N, Peters J, Booth A, Mudway I, Anstey KJ. Air pollution and dementia: a systematic review. J Alzheimers Dis. 2019;70(s1):S145–s163. https://doi.org/10.3233/JAD-180631.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cacioppo JT, Hawkley LC, Norman GJ, Berntson GG. Social isolation. Ann N Y Acad Sci. 2011;1231(1):17–22. https://doi.org/10.1111/j.1749-6632.2011.06028.x.
Article
PubMed
PubMed Central
Google Scholar
Kobayashi LC, Steptoe A. Social isolation, loneliness, and health behaviors at older ages: longitudinal cohort study. Ann Behav Med. 2018;52(7):582–93. https://doi.org/10.1093/abm/kax033.
Article
PubMed
PubMed Central
Google Scholar
World Health Organization. Risk reduction of cognitive decline and dementia. Geneva: WHO guidelines; 2019.
Google Scholar
Deckers K, van Boxtel MP, Schiepers OJ, et al. Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry. 2015;30(3):234–46. https://doi.org/10.1002/gps.4245.
Article
PubMed
Google Scholar
Killin LOJ, Starr JM, Shiue IJ, Russ TC. Environmental risk factors for dementia: a systematic review. BMC Geriatr. 2016;16(1):175. https://doi.org/10.1186/s12877-016-0342-y.
Article
PubMed
PubMed Central
Google Scholar
Kunkle BW, Grenier-Boley B, Sims R, et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414–30. https://doi.org/10.1038/s41588-019-0358-2.
Article
CAS
PubMed
PubMed Central
Google Scholar
van der Lee SJ, Wolters FJ, Ikram MK, et al. The effect of APOE and other common genetic variants on the onset of Alzheimer’s disease and dementia: a community-based cohort study. Lancet Neurol. 2018;17:434–44.
Article
PubMed
Google Scholar
Bateman RJ, Aisen PS, De Strooper B, et al. Autosomal-dominant Alzheimer’s disease: a review and proposal for the prevention of Alzheimer’s disease. Alzheimers Res Ther. 2011;3(1):1–1. https://doi.org/10.1186/alzrt59.
Article
PubMed
PubMed Central
Google Scholar
Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD. The diagnosis of young-onset dementia. Lancet Neurol. 2010;9(8):793–806. https://doi.org/10.1016/S1474-4422(10)70159-9.
Article
PubMed
PubMed Central
Google Scholar
Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 2014;83(3):253–60. https://doi.org/10.1212/WNL.0000000000000596.
Article
CAS
PubMed
PubMed Central
Google Scholar
Reiman EM, Arboleda-Velasquez JF, Quiroz YT, et al. Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun. 2020;11(1):667. https://doi.org/10.1038/s41467-019-14279-8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O, et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry. 2011;16(9):903–7. https://doi.org/10.1038/mp.2011.52.
Article
CAS
PubMed
PubMed Central
Google Scholar
Myers RH, Schaefer EJ, Wilson PW, et al. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology. 1996;46(3):673–7. https://doi.org/10.1212/WNL.46.3.673.
Article
CAS
PubMed
Google Scholar
Slooter AJ, Cruts M, Kalmijn S, et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol. 1998;55(7):964–8. https://doi.org/10.1001/archneur.55.7.964.
Article
CAS
PubMed
Google Scholar
Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255–63. https://doi.org/10.1016/S0140-6736(15)60461-5.
Article
PubMed
Google Scholar
Solomon A, Turunen H, Ngandu T, Peltonen M, Levälahti E, Helisalmi S, et al. Effect of the Apolipoprotein E Genotype on cognitive change during a multidomain lifestyle intervention: a subgroup analysis of a randomized clinical trial. JAMA Neurol. 2018;75(4):462–70. https://doi.org/10.1001/jamaneurol.2017.4365.
Article
PubMed
PubMed Central
Google Scholar
Lourida I, Hannon E, Littlejohns TJ, Langa KM, Hyppönen E, Kuzma E, et al. Association of lifestyle and genetic risk with incidence of dementia. JAMA. 2019;322(5):430–7. https://doi.org/10.1001/jama.2019.9879.
Article
PubMed
PubMed Central
Google Scholar
Licher S, Ahmad S, Karamujić-Čomić H, Voortman T, Leening MJG, Ikram MA, et al. Genetic predisposition, modifiable-risk-factor profile and long-term dementia risk in the general population. Nat Med. 2019;25(9):1364–9. https://doi.org/10.1038/s41591-019-0547-7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sharp ES, Gatz M. Relationship between education and dementia: an updated systematic review. Alzheimer Dis Assoc Disord. 2011;25(4):289–304. https://doi.org/10.1097/WAD.0b013e318211c83c.
Article
PubMed
PubMed Central
Google Scholar
Corrigan JD, Bogner J. Initial reliability and validity of the Ohio State University TBI Identification Method. J Head Trauma Rehabil. 2007;22(6):318–29. https://doi.org/10.1097/01.HTR.0000300227.67748.77.
Article
PubMed
Google Scholar
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104. https://doi.org/10.1093/eurheartj/ehy339.
Article
PubMed
Google Scholar
McKenna H, Treanor C, O’Reilly D, Donnelly M. Evaluation of the psychometric properties of self-reported measures of alcohol consumption: a COSMIN systematic review. Subst Abuse Treat Prev Policy. 2018;13(1):6. https://doi.org/10.1186/s13011-018-0143-8.
Article
PubMed
PubMed Central
Google Scholar
Razi S, Manish G, Keshav G, Sukriti K, Gupta A. Site or size of waist circumference, which one is more important in metabolic syndrome? Int J Med Public Health. 2016;6:69–72.
Article
Google Scholar
Lycke M, Lefebvre T, Cool L, van Eygen K, Boterberg T, Schofield P, et al. Screening methods for age-related hearing loss in older patients with cancer: a review of the literature. Geriatrics (Basel). 2018;3(3):48. https://doi.org/10.3390/geriatrics3030048.
Article
Google Scholar
Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255–323. https://doi.org/10.1093/eurheartj/ehz486.
Article
PubMed
Google Scholar
Levis B, Sun Y, He C, et al. Accuracy of the PHQ-2 alone and in combination with the PHQ-9 for screening to detect major depression: systematic review and meta-analysis. JAMA. 2020;323:2290–300.
Article
PubMed
PubMed Central
Google Scholar
Lubben JE. Assessing social networks among elderly populations. Fam Community Health. 1988;11(3):42–52. https://doi.org/10.1097/00003727-198811000-00008.
Article
Google Scholar
Koenig HG, Westlund RE, George LK, Hughes DC, Blazer DG, Hybels C. Abbreviating the Duke Social Support Index for use in chronically ill elderly individuals. Psychosomatics. 1993;34(1):61–9. https://doi.org/10.1016/S0033-3182(93)71928-3.
Article
CAS
PubMed
Google Scholar
Sylvia LG, Bernstein EE, Hubbard JL, Keating L, Anderson EJ. Practical guide to measuring physical activity. J Acad Nutr Diet. 2014;114(2):199–208. https://doi.org/10.1016/j.jand.2013.09.018.
Article
PubMed
Google Scholar
Desikan RS, Fan CC, Wang Y, Schork AJ, Cabral HJ, Cupples LA, et al. Genetic assessment of age-associated Alzheimer disease risk: development and validation of a polygenic hazard score. PLoS Med. 2017;14(3):e1002258. https://doi.org/10.1371/journal.pmed.1002258.
Article
PubMed
PubMed Central
Google Scholar
Escott-Price V, Sims R, Bannister C, Harold D, Vronskaya M, Majounie E, et al. Common polygenic variation enhances risk prediction for Alzheimer’s disease. Brain. 2015;138(12):3673–84. https://doi.org/10.1093/brain/awv268.
Article
PubMed
PubMed Central
Google Scholar
Tan CH, Bonham LW, Fan CC, Mormino EC, Sugrue LP, Broce IJ, et al. Polygenic hazard score, amyloid deposition and Alzheimer’s neurodegeneration. Brain. 2019;142(2):460–70. https://doi.org/10.1093/brain/awy327.
Article
PubMed
PubMed Central
Google Scholar
Holstege H, van der Lee SJ, Hulsman M, Wong TH, van Rooij JGJ, Weiss M, et al. Characterization of pathogenic SORL1 genetic variants for association with Alzheimer’s disease: a clinical interpretation strategy. Eur J Hum Genet. 2017;25(8):973–81. https://doi.org/10.1038/ejhg.2017.87.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shaw LM, Arias J, Blennow K, Galasko D, Molinuevo JL, Salloway S, et al. Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer’s disease. Alzheimers Dement. 2018;14(11):1505–21. https://doi.org/10.1016/j.jalz.2018.07.220.
Article
PubMed
Google Scholar
Janelidze S, Stomrud E, Palmqvist S, Zetterberg H, van Westen D, Jeromin A, et al. Plasma beta-amyloid in Alzheimer’s disease and vascular disease. Sci Rep. 2016;6(1):26801. https://doi.org/10.1038/srep26801.
Article
CAS
PubMed
PubMed Central
Google Scholar
Palmqvist S, Janelidze S, Stomrud E, et al. Performance of fully automated plasma assays as screening tests for Alzheimer disease-related beta-amyloid status. JAMA Neurol. 2019;76(9):1060–9. https://doi.org/10.1001/jamaneurol.2019.1632.
Janelidze S, Mattsson N, Palmqvist S, Smith R, Beach TG, Serrano GE, et al. Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia. Nat Med. 2020;26(3):379–86. https://doi.org/10.1038/s41591-020-0755-1.
Article
CAS
PubMed
Google Scholar
Thijssen EH, La Joie R, Wolf A, et al. Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration. Nat Med. 2020;26:387–97.
Article
CAS
PubMed
PubMed Central
Google Scholar
Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer’s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020;19(5):422–33. https://doi.org/10.1016/S1474-4422(20)30071-5.
Article
CAS
PubMed
Google Scholar
Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324(8):772–81. https://doi.org/10.1001/jama.2020.12134.
Article
CAS
PubMed
Google Scholar
Lewczuk P, Riederer P, O’Bryant SE, Verbeek MM, Dubois B, Visser PJ, et al. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. World J Biol Psychiatry. 2018;19(4):244–328. https://doi.org/10.1080/15622975.2017.1375556.
Article
PubMed
Google Scholar
Mattsson N, Andreasson U, Zetterberg H, Blennow K, Alzheimer’s Disease Neuroimaging I. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 2017;74(5):557–66.
Weston PSJ, Poole T, Ryan NS, Nair A, Liang Y, Macpherson K, et al. Serum neurofilament light in familial Alzheimer disease: a marker of early neurodegeneration. Neurology. 2017;89(21):2167–75. https://doi.org/10.1212/WNL.0000000000004667.
Article
PubMed
PubMed Central
Google Scholar
Preische O, Schultz SA, Apel A, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease. Nat Med. 2019;25(2):277–83. https://doi.org/10.1038/s41591-018-0304-3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chhatwal JP, Schultz AP, Dang Y, Ostaszewski B, Liu L, Yang HS, et al. Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals. Nat Commun. 2020;11(1):6024. https://doi.org/10.1038/s41467-020-19543-w.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cullen NC, Leuzy A, Palmqvist S, et al. Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations. Nature Aging. 2020;1:114–23. https://doi.org/10.1038/s43587-020-00003-5.
Bateman RJ, Xiong C, Benzinger TLS, et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med. 2012;367:795–804.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rohrer JD, Nicholas JM, Cash DM, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative ( GENFI ) study: a cross-sectional analysis. Lancet Neurol. 2015;14:253–62.
Article
PubMed
PubMed Central
Google Scholar
Schott JM, Fox NC, Frost C, Scahill RI, Janssen JC, Chan D, et al. Assessing the onset of structural change in familial Alzheimer’s disease. Ann Neurol. 2003;53(2):181–8. https://doi.org/10.1002/ana.10424.
Article
PubMed
Google Scholar
Fox NC, Freeborough PA, Rossor MN. Visualisation and quantification of rates of atrophy in Alzheimer’s disease. Lancet. 1996;348(9020):94–7. https://doi.org/10.1016/S0140-6736(96)05228-2.
Article
CAS
PubMed
Google Scholar
Frisoni GB, Fox NC, Jack CR, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol. 2010;6(2):67–77. https://doi.org/10.1038/nrneurol.2009.215.
Article
PubMed
PubMed Central
Google Scholar
Hill DLG, Schwarz AJ, Isaac M, et al. Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer’s disease. Alzheimers Dement. 2014;10:421–429.e423.
Article
PubMed
Google Scholar
Lombardi G, Crescioli G, Cavedo E, et al. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer’s disease in people with mild cognitive impairment. Cochrane Database Syst Rev. 2020;3(3):CD009628. https://doi.org/10.1002/14651858.CD009628.pub2.
Rittman T. Neurological update: neuroimaging in dementia. J Neurol. 2020;267(11):3429–35. https://doi.org/10.1007/s00415-020-10040-0.
Article
PubMed
PubMed Central
Google Scholar
Veldsman M, Tai X-Y, Nichols T, Smith S, Peixoto J, Manohar S, et al. Cerebrovascular risk factors impact frontoparietal network integrity and executive function in healthy ageing. Nat Commun. 2020;11(1):4340. https://doi.org/10.1038/s41467-020-18201-5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38. https://doi.org/10.1016/S1474-4422(13)70124-8.
Article
PubMed
PubMed Central
Google Scholar
Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341(jul26 1):c3666. https://doi.org/10.1136/bmj.c3666.
Article
PubMed
PubMed Central
Google Scholar
Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H, et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. Bmj. 2009;339(jul06 1):b2477. https://doi.org/10.1136/bmj.b2477.
Article
PubMed
PubMed Central
Google Scholar
Kuźma E, Lourida I, Moore SF, Levine DA, Ukoumunne OC, Llewellyn DJ. Stroke and dementia risk: a systematic review and meta-analysis. Alzheimers Dement. 2018;14(11):1416–26. https://doi.org/10.1016/j.jalz.2018.06.3061.
Article
PubMed
PubMed Central
Google Scholar
Bos D, Wolters FJ, Darweesh SKL, Vernooij MW, de Wolf F, Ikram MA, et al. Cerebral small vessel disease and the risk of dementia: a systematic review and meta-analysis of population-based evidence. Alzheimers Dement. 2018;14(11):1482–92. https://doi.org/10.1016/j.jalz.2018.04.007.
Article
PubMed
Google Scholar
Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967–72. https://doi.org/10.1136/jnnp.55.10.967.
Article
CAS
PubMed
PubMed Central
Google Scholar
Koedam EL, Lehmann M, van der Flier WM, et al. Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol. 2011;21(12):2618–25. https://doi.org/10.1007/s00330-011-2205-4.
Article
PubMed
PubMed Central
Google Scholar
Pasquier F, Leys D, Weerts JG, Mounier-Vehier F, Barkhof F, Scheltens P. Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol. 1996;36(5):268–72. https://doi.org/10.1159/000117270.
Article
CAS
PubMed
Google Scholar
Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32(6):1318–22. https://doi.org/10.1161/01.STR.32.6.1318.
Article
CAS
PubMed
Google Scholar
Vernooij MW, Pizzini FB, Schmidt R, Smits M, Yousry TA, Bargallo N, et al. Dementia imaging in clinical practice: a European-wide survey of 193 centres and conclusions by the ESNR working group. Neuroradiology. 2019;61(6):633–42. https://doi.org/10.1007/s00234-019-02188-y.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351–6. https://doi.org/10.2214/ajr.149.2.351.
Article
CAS
PubMed
Google Scholar
Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, et al. The cortical signature of Alzheimer’s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 2009;19(3):497–510. https://doi.org/10.1093/cercor/bhn113.
Article
PubMed
Google Scholar
Giorgio J, Landau SM, Jagust WJ, Tino P, Kourtzi Z. Alzheimer’s Disease Neuroimaging I. Modelling prognostic trajectories of cognitive decline due to Alzheimer’s disease. Neuroimage Clin. 2020;26:102199. https://doi.org/10.1016/j.nicl.2020.102199.
Article
PubMed
PubMed Central
Google Scholar
Archetti D, Ingala S, Venkatraghavan V, Wottschel V, Young AL, Bellio M, et al. Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer’s disease. NeuroImage Clin. 2019;24:101954. https://doi.org/10.1016/j.nicl.2019.101954.
Article
PubMed
PubMed Central
Google Scholar
Fisher CK, Smith AM, Walsh JR. Machine learning for comprehensive forecasting of Alzheimer’s disease progression. Sci Rep. 2019;9(1):1–14. https://doi.org/10.1038/s41598-019-49656-2.
Article
CAS
Google Scholar
Pilotto A, Premi E, Paola Caminiti S, Presotto L, Turrone R, Alberici A, et al. Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease. Neurology. 2018;90(12):e1029–37. https://doi.org/10.1212/WNL.0000000000005161.
Article
PubMed
Google Scholar
Rowe CC, Ellis KA, Rimajova M, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging. 2010;31:1275–83.
Article
PubMed
Google Scholar
Lowe VJ, Curran G, Fang P, Liesinger AM, Josephs KA, Parisi JE, et al. An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun. 2016;4(1):58. https://doi.org/10.1186/s40478-016-0315-6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Endres CJ, Pomper MG, James M, Uzuner O, Hammoud DA, Watkins CC, et al. Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans. J Nuclear Med. 2009;50(8):1276–82. https://doi.org/10.2967/jnumed.109.062265.
Article
CAS
Google Scholar
Nabulsi NB, Mercier J, Holden D, Carré S, Najafzadeh S, Vandergeten MC, et al. Synthesis and preclinical evaluation of 11C-UCB-J as a PET Tracer for imaging the synaptic vesicle glycoprotein 2A in the brain. J Nuclear Med. 2016;57(5):777–84. https://doi.org/10.2967/jnumed.115.168179.
Article
CAS
Google Scholar
Hou XH, Feng L, Zhang C, Cao XP, Tan L, Yu JT. Models for predicting risk of dementia: a systematic review. J Neurol Neurosurg Psychiatry. 2019;90(4):373–9. https://doi.org/10.1136/jnnp-2018-318212.
Article
PubMed
Google Scholar
Tang EY, Harrison SL, Errington L, et al. Current developments in dementia risk prediction modelling: an updated systematic review. PLoS One. 2015;10:e0136181.
Article
PubMed
PubMed Central
Google Scholar
Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 2006;5(9):735–41. https://doi.org/10.1016/S1474-4422(06)70537-3.
Article
PubMed
Google Scholar
Anstey KJ, Cherbuin N, Herath PM. Development of a new method for assessing global risk of Alzheimer’s disease for use in population health approaches to prevention. Prev Sci. 2013;14(4):411–21. https://doi.org/10.1007/s11121-012-0313-2.
Article
PubMed
PubMed Central
Google Scholar
Anstey KJ, Cherbuin N, Herath PM, Qiu C, Kuller LH, Lopez OL, et al. A self-report risk index to predict occurrence of dementia in three independent cohorts of older adults: the ANU-ADRI. PLoS One. 2014;9(1):e86141. https://doi.org/10.1371/journal.pone.0086141.
Article
CAS
PubMed
PubMed Central
Google Scholar
Barnes DE, Beiser AS, Lee A, et al. Development and validation of a brief dementia screening indicator for primary care. Alzheimers Dement. 2014;10:656–665.e651.
Article
PubMed
PubMed Central
Google Scholar
Exalto LG, Biessels GJ, Karter AJ, et al. Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol. 2013;1(3):183–90. https://doi.org/10.1016/S2213-8587(13)70048-2.
Tang EYH, Price CI, Robinson L, Exley C, Desmond DW, Köhler S, et al. Assessing the predictive validity of simple dementia risk models in harmonised stroke cohorts. Stroke. 2020;51(7):2095–102. https://doi.org/10.1161/STROKEAHA.120.027473.
Article
PubMed
PubMed Central
Google Scholar
Stephan BCM, Pakpahan E, Siervo M, Licher S, Muniz-Terrera G, Mohan D, et al. Prediction of dementia risk in low-income and middle-income countries (the 10/66 Study): an independent external validation of existing models. Lancet Glob Health. 2020;8(4):e524–35. https://doi.org/10.1016/S2214-109X(20)30062-0.
Article
PubMed
PubMed Central
Google Scholar